Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566787 · ClinicalTrials.gov registry record · Phase 3
Concomitant Treatment of Permanent Atrial Fibrillation
A Phase 3 study, sponsored by AtriCure.
- Completed
- Registry status
- Phase 3
- Development phase
- 39
- Enrollment target
NCT00566787: Completed Phase 3 study, sponsored by AtriCure.
NCT00566787 is a Phase 3 study that has completed, run by AtriCure. The registered enrollment target is 39 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00566787, a Phase 3 study, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 39 participants
- Enrollment target
Study Summary
RESTORE-SR study is a multi-center, prospective, nonrandomized study with case matched concurrent controls to evaluate the safety and efficacy of the AtriCure Bipolar System
Interventions
- DEVICE Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-11 |
| Phase | Phase 3 |
What the finished NCT00566787 record still lists
NCT00566787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System is the first listed.
NCT00566787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00566787 about?
NCT00566787 is a clinical study titled "Concomitant Treatment of Permanent Atrial Fibrillation". RESTORE-SR study is a multi-center, prospective, nonrandomized study with case matched concurrent controls to evaluate the safety and efficacy of the AtriCure Bipolar System
What is the current status of trial NCT00566787?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 39 participants. The study started on 2005-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00566787?
The interventions under investigation include: Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System (DEVICE).
Who is sponsoring clinical trial NCT00566787?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00566787's enrollment target sits among peer trials
39 1898th of 2000 higher than 101 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia